Morning Update: Revisiting thalidomide survivors
Good morning. The Globe spoke with thalidomide survivors about how their lives have changed 10 years after a…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…
Milestone Receives FDA Approval of CARDAMYST™ (etripamil)
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed…
Nasal Spray Recalled Nationwide Due to Mold & Bacteria
ReBoost Nasal Spray is recalled nationwide due to yeast, mold and microbial contamination.The bacteria can cause severe infections,…
New rules around medication dispensing delayed after political backlash – The Irish Times
Changes to the way medication is dispensed to patients from pharmacies are to be delayed after political backlash…
Traveling with meds? Brittney Griner shares the risks she learned
Traveling with prescription medicine? Know the laws before you go Learn why checking prescription drug laws before traveling…
Nationwide recall: FDA warns mold in nasal spray could lead to life-threatening illness
The U.S. Food and Drug Administration is warning consumers about a nationwide recall involving nasal sprays that could…
New York Times Gets the Story on Prescription Drug Prices Wrong
Photo by Wonderlane A friend correctly harangued me about this New York Times piece on Donald Trump’s deal…
Docs call for GLP-1 warning label due to ‘very dangerous’ risk
There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in…
Is ozempic forever? UK surgeon explains how GLP-1 drugs work, and whether you need to take them indefinitely
Weight-loss drugs, especially GLP-1 medications, have surged in popularity as more people turn to them in the hope…
Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 December 2025) approved the medicine mirdametinib (Ezmekly) for…
Medication-Free Treatment in Norway Found Effective Over the Short Term
In 2015, when the Norwegian Minister of Health ordered the country’s four regional health authorities to set aside…